Brought to you by 
Degusssa AG sells off Viatris unit in LBO
09 Sep 2020
Executive Summary
In its strategy to get out of all businesses except specialty chemicals, Degusssa AG has sold its Viatris unit in a leveraged buyout. Viatris was part of the pharmaceutical company Asta Medica GMBH, which Degussa has been divesting piece by piece.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Degusssa AG sells off Viatris unit in LBO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice